Search
for
Sort by
Research 91–120 of 1000+
- Alopecia areata treatment with baricitinib: different relapse phenotypes
- Hair for the Long Haul: Alopecia Areata Cases and Considerations
- Skin Biology and Ageing
- Gene Expression During Drosophila Wing Morphogenesis and Differentiation
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Efficacy and predictive markers of response to tofacitinib and baricitinib therapy in alopecia areata: A 52-week comparative cohort study
- Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Az alopecia areata kezelésében alkalmazott baricitinib hatásosságának és biztonságosságának retrospektív vizsgálata = Efficacy and safety of baricitinib treatment in alopecia areata:a retrospective analysis
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Evidence for the off-label use of tofacitinib in alopecia areata
- Safety and Efficacy of Ritlecitinib for the Treatment of Patients with Alopecia Areata: A Systematic Review and Meta-Analysis of Controlled Trials
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Alopecia: Association with Resistance to Thyroid Hormones
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Janus Kinase inhibitors in dermatology: a review
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- Comparative Efficacy Evaluation of Alopecia Areata Management with Janus Kinase Inhibitors in Children: Retrospective Cohort Study
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience